Journal article

Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature

Guillaume Ploussard, Nicola Fossati, Thomas Wiegel, Anthony D'Amico, Michael S Hofman, Silke Gillessen, Nicolas Mottet, Steven Joniau, Daniel E Spratt

European Urology Oncology | ELSEVIER | Published : 2021

Abstract

CONTEXT: The prognosis and optimal management of pN0/pN1 patients with persistently elevated prostate-specific antigen (PSA) 6-8 wk after radical prostatectomy (RP) remain unclear. OBJECTIVE: To perform a systematic review of oncologic outcomes and effectiveness of salvage therapies in men with a detectable PSA level after RP. EVIDENCE ACQUISITION: A systematic review was performed in May 2020. A total of 2374 articles were screened, and 25 studies including 5217 men were selected and included in the systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. EVIDENCE SYNTHESIS: PSA persistence was most commonly defined as PSA >0..

View full abstract